Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? KA Brogden Nature reviews microbiology 3 (3), 238-250, 2005 | 7055 | 2005 |
Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs CS Rogers, DA Stoltz, DK Meyerholz, LS Ostedgaard, T Rokhlina, PJ Taft, ... Science 321 (5897), 1837-1841, 2008 | 880 | 2008 |
Antimicrobial peptides in animals and their role in host defences KA Brogden, M Ackermann, PB McCray Jr, BF Tack International journal of antimicrobial agents 22 (5), 465-478, 2003 | 639 | 2003 |
Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth DA Stoltz, DK Meyerholz, AA Pezzulo, S Ramachandran, MP Rogan, ... Science translational medicine 2 (29), 29ra31-29ra31, 2010 | 571 | 2010 |
Human polymicrobial infections KA Brogden, JM Guthmiller, CE Taylor The Lancet 365 (9455), 253-255, 2005 | 435 | 2005 |
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? NK Brogden, KA Brogden International journal of antimicrobial agents 38 (3), 217-225, 2011 | 399 | 2011 |
Thematic review series: skin lipids. Antimicrobial lipids at the skin surface DR Drake, KA Brogden, DV Dawson, PW Wertz Journal of lipid research 49 (1), 4-11, 2008 | 372 | 2008 |
Pasteurella haemolytica complicated respiratory infections in sheep and goats KA Brogden, HD Lehmkuhl, RC Cutlip Veterinary research 29 (3-4), 233-254, 1998 | 324 | 1998 |
The nervous system and innate immunity: the neuropeptide connection KA Brogden, JM Guthmiller, M Salzet, M Zasloff Nature immunology 6 (6), 558-564, 2005 | 300 | 2005 |
The porcine lung as a potential model for cystic fibrosis CS Rogers, WM Abraham, KA Brogden, JF Engelhardt, JT Fisher, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 295 (2 …, 2008 | 296 | 2008 |
Human oral mucosa: development, structure and function C Squier, K Brogden John Wiley & Sons, 2010 | 286 | 2010 |
Gallinacin-3, an inducible epithelial β-defensin in the chicken C Zhao, T Nguyen, L Liu, RE Sacco, KA Brogden, RI Lehrer Infection and immunity 69 (4), 2684-2691, 2001 | 247 | 2001 |
Influence of smoking on gingival crevicular fluid cytokines in severe chronic periodontitis KD Tymkiw, DH Thunell, GK Johnson, S Joly, KK Burnell, JE Cavanaugh, ... Journal of clinical periodontology 38 (3), 219-228, 2011 | 243 | 2011 |
Antibacterial activity of sphingoid bases and fatty acids against Gram-positive and Gram-negative bacteria CL Fischer, DR Drake, DV Dawson, DR Blanchette, KA Brogden, ... Antimicrobial agents and chemotherapy 56 (3), 1157-1161, 2012 | 238 | 2012 |
Response of the ruminant respiratory tract to Mannheimia (Pasteurella) haemolytica MR Ackermann, KA Brogden Microbes and infection 2 (9), 1079-1088, 2000 | 236 | 2000 |
Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica. KA Brogden, AJ De Lucca, J Bland, S Elliott Proceedings of the National Academy of Sciences 93 (1), 412-416, 1996 | 218 | 1996 |
Polymicrobial diseases of animals and humans KA Brogden Polymicrobial diseases, 1-20, 2002 | 211 | 2002 |
A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy DH Thunell, KD Tymkiw, GK Johnson, S Joly, KK Burnell, JE Cavanaugh, ... Journal of periodontal research 45 (1), 148-152, 2010 | 204 | 2010 |
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice K Li, CL Wohlford-Lenane, R Channappanavar, JE Park, JT Earnest, ... Proceedings of the National Academy of Sciences 114 (15), E3119-E3128, 2017 | 176 | 2017 |
Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes O Shamova, KA Brogden, C Zhao, T Nguyen, VN Kokryakov, RI Lehrer Infection and Immunity 67 (8), 4106-4111, 1999 | 164 | 1999 |